Skip to main content

Table 1 Patient characteristics (n = 45)

From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy

Parameter Gal-1 expression (weak) Gal-1 expression (strong) p value
Age (years)    0.464
  <  50 5 (45.5%) 10 (29.4%)  
 ≥ 50 6 (54.5%) 24 (70.6%)  
Gender    0.732
 Female 5 (45.5%) 13 (38.2%)  
 Male 6 (54.5%) 21 (61.8%)  
ECOG    1.000
 0–2 8 (72.7%) 26 (76.5%)  
 3–4 3 (27.3%) 8 (23.5%)  
Tumor size    0.897
  <  5 cm 3 (27.3%) 7 (20.6%)  
 ≥ 5 cm 2 (18.2%) 7 (20.6%)  
 Unknown 6 (54.5%) 20 (58.8%)  
OP method    0.525
 gross total removal 8 (72.7%) 17 (50.0%)  
 subtotal removal + biopsy 3 (27.3%) 14 (41.2%)  
 unknown 0 (0%) 3 (8.8%)  
RT field    0.736
 Small 7 (63.6%) 19 (55.9%)  
 Whole brain 4 (36.4%) 15 (44.1%)  
EQD2 (Gy)    0.987
 Mean 66.36 66.38  
 SEM 0.67 0.46  
  1. EQD2 equivalent dose in 2-Gy fractions, OP operation, RT radiotherapy